Meadowbrook Wealth Management
ABBV icon

Meadowbrook Wealth Management’s AbbVie ABBV Stock Holding History

Meadowbrook Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.97M Buy
15,184
+2,130
+16% +$546K 4.16% 5
2026
Q2 		$3.28M Sell
13,054
-7,750
-37% -$1.67M 3.54% 7
2026
Q1 		$4.52M Sell
20,804
-835
-4% -$185K 6% 3
2025
Q4 		$4.94M Buy
21,639
+5,050
+30% +$1.15M 5.64% 4
2025
Q3 		$3.84M Buy
+16,589
New +$3.38M 3.99% 5

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Meadowbrook Wealth Management's ABBV Position: Q3 2026 in Review

Meadowbrook Wealth Management increased its AbbVie (ABBV) stake by 16% in Q3 2026, buying an estimated $546K and bringing the position to 15,184 shares worth $3.97M. The position accounts for 4.16% of the portfolio, ranked #5.

Meadowbrook Wealth Management first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. The position peaked at $4.94M in Q4 2025. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Meadowbrook Wealth Management held 15,184 shares of AbbVie worth $3.97M as of Q3 2026.
  • Meadowbrook Wealth Management bought 2,130 AbbVie shares in Q3 2026, an estimated $546K.
  • AbbVie made up 4.16% of Meadowbrook Wealth Management's portfolio in Q3 2026, its #5 holding.
  • Meadowbrook Wealth Management first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
  • Meadowbrook Wealth Management's AbbVie position peaked at $4.94M in Q4 2025.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Meadowbrook Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.